B18.1 Chronic viral hepatitis B without delta-agent

Name of the Condition

• Chronic viral hepatitis B without delta-agent

Summary

Chronic viral hepatitis B without delta-agent is a persistent liver inflammation caused by the hepatitis B virus (HBV) alone, lasting six months or longer. It can lead to progressive liver damage, fibrosis, cirrhosis, or hepatocellular carcinoma if left untreated. The condition often remains asymptomatic in early stages but may present with nonspecific symptoms as it advances.

Causes

Chronic viral hepatitis B without delta-agent is caused by the hepatitis B virus (HBV). HBV is transmitted through blood, sexual contact, or perinatal exposure. Unlike infections involving the delta agent (hepatitis D virus), this condition occurs in the absence of HDV co-infection, meaning the virus replicates independently without requiring HBV surface antigens for its envelope.

Risk Factors

• Chronic infection with HBV.
• Unprotected sexual contact with an infected individual.
• Sharing needles or other drug paraphernalia.
• Blood transfusions or organ transplants prior to widespread screening.
• Perinatal exposure to HBV.
• Immunocompromised states, such as HIV co-infection.

Symptoms

• Fatigue, malaise, or unexplained weight loss.
• Abdominal discomfort, particularly in the right upper quadrant.
• Jaundice (yellowing of the skin or eyes).
• Dark urine or pale stools.
• Easy bruising or bleeding due to impaired liver function.

Diagnosis

Diagnosis involves serologic testing to detect HBV antigens and antibodies, such as HBsAg, anti-HBc, and anti-HBs. Liver function tests (LFTs) assess hepatic injury, while imaging (e.g., ultrasound) or biopsy may evaluate fibrosis or cirrhosis. Testing for HDV is performed to exclude co-infection, confirming the absence of the delta agent.

Treatment Options

Treatment focuses on antiviral therapy (e.g., nucleos(t)ide analogs) to suppress viral replication and reduce liver damage. Regular monitoring of viral load and liver function is essential. In advanced cases, management may include addressing complications like cirrhosis or hepatocellular carcinoma.

Prognosis and Follow-Up

Prognosis varies based on viral activity, liver damage, and response to treatment. Regular follow-up with liver function tests, viral load monitoring, and imaging is critical to detect progression. Early intervention can slow or prevent severe outcomes like cirrhosis or cancer.

Complications

• Progressive liver fibrosis or cirrhosis.
• Hepatocellular carcinoma.
• Liver failure.
• Increased risk of other infections due to impaired immunity.

Lifestyle & Prevention

• Vaccination against HBV to prevent infection.
• Safe sex practices and avoiding sharing needles.
• Regular screening for at-risk individuals.
• Limiting alcohol and avoiding hepatotoxic substances.

When to Seek Professional Help

Seek care if experiencing persistent fatigue, jaundice, abdominal pain, or unexplained weight loss. Prompt evaluation is necessary for those with known HBV exposure or risk factors to initiate timely management.

Tips for Medical Coders

Use B18.1 for chronic viral hepatitis B without delta-agent. Document the absence of HDV co-infection to support code assignment. Include details on viral status, liver function, and any associated complications to ensure accurate coding and clinical correlation.